400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Immunology/Inflammation / FLAP / Masoprocol
CAS No.: 27686-84-6
Synonyms: meso-Nordihydroguaiaretic acid;meso-NDGA;CHX-100
Masoprocol is an antineoplastic drug used to treat skin growths caused by sun exposure. A form of nordihydroguaiaretic acid that is taken by mouth is being studied in the treatment of prostate cancer.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT00259818 | Cancer | Phase 1 | Completed | - | United States, Arizona ... more >> Premiere Oncology of Arizona Scottsdale, Arizona, United States United States, New York Albert Einstein College of Medicine Bronx, New York, United States United States, Tennessee Sarah Cannon Cancer Center Nashville, Tennessee, United States Collapse << |
NCT00664586 | Refractory Solid Tumors ... more >> Lymphoma Collapse << | Phase 1 | Terminated(Funding constraints... more >>) Collapse << | - | United States, Tennessee ... more >> The Sarah Cannon Cancer Center Nashville, Tennessee, United States, 37203 Collapse << |
NCT00664677 | Leukemias Acu... more >>te Myeloid Leukemia (AML) Acute Lymphocytic Leukemia (ALL) Adult T Cell Leukemia (ATL) Chronic Myeloid Leukemia (CML-BP) Chronic Lymphocytic Leukemia (CLL) Myelodysplastic Syndrome (MDS) Chronic Myelomonocytic Leukemia (CMML) Collapse << | Phase 1 | Terminated(Funding constraints... more >>) Collapse << | - | United States, North Carolina ... more >> UNC, Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 Collapse << |
实验方案
技术信息
CAS号 | 27686-84-6 | 储存条件 |
|
|
分子式 | C18H22O4 | 运输 | 蓝冰 | |
分子量 | 302.36 | 别名 | meso-Nordihydroguaiaretic acid;meso-NDGA;CHX-100 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT00259818 | Cancer | Phase 1 | Completed | - | United States, Arizona ... more >> Premiere Oncology of Arizona Scottsdale, Arizona, United States United States, New York Albert Einstein College of Medicine Bronx, New York, United States United States, Tennessee Sarah Cannon Cancer Center Nashville, Tennessee, United States Collapse << |
NCT00664586 | Refractory Solid Tumors ... more >> Lymphoma Collapse << | Phase 1 | Terminated(Funding constraints... more >>) Collapse << | - | United States, Tennessee ... more >> The Sarah Cannon Cancer Center Nashville, Tennessee, United States, 37203 Collapse << |
NCT00664677 | Leukemias Acu... more >>te Myeloid Leukemia (AML) Acute Lymphocytic Leukemia (ALL) Adult T Cell Leukemia (ATL) Chronic Myeloid Leukemia (CML-BP) Chronic Lymphocytic Leukemia (CLL) Myelodysplastic Syndrome (MDS) Chronic Myelomonocytic Leukemia (CMML) Collapse << | Phase 1 | Terminated(Funding constraints... more >>) Collapse << | - | United States, North Carolina ... more >> UNC, Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 Collapse << |
NCT02575794 | High Grade Glioma (III or IV) | Phase 1 | Recruiting | December 15, 2022 | United States, Alabama ... more >> UAB Comprehensive Cancer Center Not yet recruiting Birmingham, Alabama, United States, 35294-3410 Contact: Thiru Pillay, RN 205-934-1842 thiru@uab.edu Principal Investigator: Burt Nabors, MD United States, California Jonsson Comprehensive Cancer Center at UCLA Not yet recruiting Los Angeles, California, United States, 90095 Contact: Timothy Cloughesy, MD 310-825-5321 TCloughesy@mednet.ucla.edu Principal Investigator: Timothy Cloughesy, MD United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21231 Contact: Quinn qta@jhmi.edu, RN 410-955-8837 qta@jhmi.edu Contact: Trisha Surakus 410-502-9864 tsuraku1@jhmi.edu Sub-Investigator: Matthias Holdhoff, MD Principal Investigator: Stuart Grossman, MD United States, Massachusetts Dana Farber Cancer Institute Not yet recruiting Boston, Massachusetts, United States, 02215 Contact: Jennifer Barrs 617-632-6119 JenniferA_Barrs@DFCI.HARVARD.EDU Principal Investigator: Patrick Wen, MD United States, Michigan Josephine Ford Cancer Center at Henry Ford Hospital Recruiting Detroit, Michigan, United States, 48202 Contact: Amy Williamson, RN awillia12@hfhs.org Contact: Emily Krozek, MHSA Ekrozek1@hfhs.org Principal Investigator: Tobias Walbert, MD United States, North Carolina Wake Forest University Comprehensive Cancer Center Not yet recruiting Winston-Salem, North Carolina, United States, 27157 Contact: Clinical Trials Office 336-713-6771 Principal Investigator: Glenn Lesser, MD United States, Ohio Cleveland Clinic Taussig Cancer Center Not yet recruiting Cleveland, Ohio, United States, 44195 Contact: Cancer Center-Cares 216-444-7923 Sub-Investigator: David Peereboom, MD United States, Pennsylvania Abrams Cancer Center of the University of Pennsylvania Not yet recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Clinical Trials Office-Abrams Cancer Center 800-474-9892 Principal Investigator: Arati Desai, MD Hillman Cancer Center at University of Pittsburgh Cancer Institute Not yet recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: Clinical Trials Office - UPMC Cancer Centers 412-647-8073 Principal Investigator: Frank Lieberman, MD Collapse << |
NCT00154089 | Cervical Intraepithelial Neopl... more >>asia Collapse << | Phase 1 Phase 2 | Completed | - | United States, Maryland ... more >> University of Maryland, Dept. of Family Medicine Baltimore, Maryland, United States, 21201 Collapse << |
NCT00057512 | Head and Neck Neoplasms | Phase 1 | Completed | - | United States, South Carolina ... more >> MUSC Charleston, South Carolina, United States, 29475 Collapse << |
NCT00404248 | Brain and Central Nervous Syst... more >>em Tumors Collapse << | Phase 1 Phase 2 | Completed | - | United States, Alabama ... more >> UAB Comprehensive Cancer Center Birmingham, Alabama, United States, 35294-3410 United States, Florida H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa, Florida, United States, 33612-9497 United States, Georgia Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Michigan Josephine Ford Cancer Center at Henry Ford Hospital Detroit, Michigan, United States, 48202 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 United States, Pennsylvania Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Collapse << |
NCT00404248 | - | - | Completed | - | - |
NCT00313534 | Prostate Cancer | Phase 1 | Terminated(Ran out of drug) | - | United States, California ... more >> UCSF Comprehensive Cancer Center San Francisco, California, United States, 94115 Collapse << |
NCT00678015 | Prostate Cancer | Phase 2 | Terminated(Per protocol - inte... more >>rim analysis showed no significant PSA declines among the first 12 patients after 3 cycles of treatment) Collapse << | - | United States, California ... more >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 Collapse << |
NCT00678015 | - | - | Terminated(Per protocol - inte... more >>rim analysis showed no significant PSA declines among the first 12 patients after 3 cycles of treatment) Collapse << | - | - |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网